BioCentury | Mar 4, 2019
Distillery Therapeutics

Inhibiting soluble epoxide hydrolase for renal damage

...Phase I testing for diabetes and chronic obstructive pulmonary disease (COPD). TMS Co. Ltd. has TMS-00X...
BioCentury | Apr 25, 2017
Distillery Therapeutics

Dental

...inhibitor, in Phase I testing for chronic obstructive pulmonary disease (COPD). TMS Co. Ltd. has TMS-00X...
Items per page:
1 - 2 of 2